E-Cigarette Perception for E-Cigarette Use

Overseen By Danielle R Davis, PhD

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Yale University

Must not be taking: Psychoactive drugs

Disqualifiers: Significant medical concerns, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

What You Need to Know Before You Apply

What is the purpose of this trial?

This study examines differences between males and females in the appeal and addiction potential of menthol flavored e-cigarettes with and without nicotine.

Who Is on the Research Team?

Danielle R Davis, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for English-reading individuals who currently smoke cigarettes, have used e-cigarettes before, and are not trying to quit tobacco. Participants must also have their cigarette use confirmed through biochemical tests.

Inclusion Criteria

I can read and write in English.

I currently smoke cigarettes.

I have used e-cigarettes before.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Sampling Session

Participants will sample and rate three menthol flavored e-cigarettes with varying levels of nicotine

1 day

1 visit (in-person)

Concurrent Choice Session

Participants will make choices between two menthol e-cigarettes with different levels of nicotine

1 day

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

2-4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Nicotine Level 1 (0mg/ml)
• Nicotine Level 2 (36mg/ml)
• Nicotine Level 3 (59mg/ml)

Trial Overview

The study is looking at how appealing and addictive menthol flavored e-cigarettes are by comparing three nicotine levels: none (0mg/ml), medium (36mg/ml), and high (59mg/ml) between male and female participants.

How Is the Trial Designed?

Group I: Sampling Session - Lab 1 Experimental Treatment 3 Interventions

Participants will sample and rate three menthol flavored e-cigarettes with varying levels of nicotine.

Group II: Concurrent Choice Session- Lab 2 Experimental Treatment 2 Interventions

Participants will make choices between two menthol e-cigarettes with different levels of nicotine.

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+